甲状腺炎与 SARS-CoV-2 大流行：综述。
Thyroiditis and SARS-CoV-2 pandemic: a review.
机构信息
Department of Endocrinology and Metabolic diseases, Cardiovascular and Metabolic Unit CHU-Larrey, Toulouse, France.
出版信息
Endocrine. 2021 May;72(2):326-331. doi: 10.1007/s12020-021-02689-y. Epub 2021 Mar 27.
Abstract
The world is dealing with the Covid-19 pandemic due to the coronavirus SARS-CoV-2. Amongst the extra-pulmonary manifestations presented by Covid-19 patients, thyroiditis form part of the spectrum of visceral involvement linked to SARS-CoV-2. In this review, we will describe the various documented clinical forms of thyroiditis (inflammatory thyroiditis, subacute or de Quervain's thyroiditis, chronic lymphocytic thyroiditis or Hashimoto's disease, painless (silent) postpartum thyroiditis) to facilitate their diagnosis in more or less symptomatic Covid-19 patients and to provide guidance for patient treatment.
摘要
由于冠状病毒 SARS-CoV-2，世界正在应对 COVID-19 大流行。在 COVID-19 患者出现的肺外表现中，甲状腺炎是与 SARS-CoV-2 相关的内脏受累谱的一部分。在这篇综述中，我们将描述各种已记录的甲状腺炎临床形式（炎症性甲状腺炎、亚急性或 De Quervain 甲状腺炎、慢性淋巴细胞性甲状腺炎或桥本氏病、无痛（沉默）产后甲状腺炎），以促进在或多或少有症状的 COVID-19 患者中诊断这些疾病，并为患者治疗提供指导。
相似文献
1
Thyroiditis and SARS-CoV-2 pandemic: a review.甲状腺炎与 SARS-CoV-2 大流行：综述。
Endocrine. 2021 May;72(2):326-331. doi: 10.1007/s12020-021-02689-y. Epub 2021 Mar 27.
2
Incidence of De Quervain's thyroiditis during the COVID-19 pandemic in an area heavily affected by Sars-CoV-2 infection.在 SARS-CoV-2 感染严重地区，COVID-19 大流行期间的德奎尔万甲状腺炎发病率。
Endocrine. 2021 Nov;74(2):215-218. doi: 10.1007/s12020-021-02841-8. Epub 2021 Aug 7.
3
COVID-19 vaccine-associated subacute thyroiditis: an unusual suspect for de Quervain's thyroiditis.COVID-19 疫苗相关亚急性甲状腺炎：桥本病的不常见病因。
BMJ Case Rep. 2021 Nov 9;14(11):e246425. doi: 10.1136/bcr-2021-246425.
4
SARS-CoV-2: a potential trigger for subacute thyroiditis? Insights from a case report.严重急性呼吸综合征冠状病毒2：亚急性甲状腺炎的潜在诱因？ 一项病例报告的见解
J Endocrinol Invest. 2020 Aug;43(8):1171-1172. doi: 10.1007/s40618-020-01312-7. Epub 2020 Jun 2.
5
Hashimoto's thyroiditis simulating De Quervain's thyroiditis.桥本甲状腺炎酷似亚急性甲状腺炎。
J Adolesc Health Care. 1988 Sep;9(5):434-5. doi: 10.1016/0197-0070(88)90045-9.
6
[SUBACUTE THYROIDITIS AND COVID-19 (REVIEW)].[亚急性甲状腺炎与新型冠状病毒肺炎（综述）]
Georgian Med News. 2021 Feb(311):98-103.
7
Subacute Thyroiditis After Sars-COV-2 Infection.感染 SARS-CoV-2 后发生亚急性甲状腺炎。
J Clin Endocrinol Metab. 2020 Jul 1;105(7). doi: 10.1210/clinem/dgaa276.
8
Autoimmune and inflammatory thyroid diseases following vaccination with SARS-CoV-2 vaccines: from etiopathogenesis to clinical management.自身免疫和炎症性甲状腺疾病与 SARS-CoV-2 疫苗接种相关：从发病机制到临床管理。
Endocrine. 2022 Dec;78(3):406-417. doi: 10.1007/s12020-022-03118-4. Epub 2022 Jun 28.
9
[Difficulties in the diagnosis of painful Hashimoto's thyroiditis--case report].[疼痛性桥本甲状腺炎的诊断难点——病例报告]
Pol Merkur Lekarski. 2012 Apr;32(190):238-41.
10
Subacute thyroiditis after vaccination against SARS-CoV-2.接种新型冠状病毒疫苗后发生的亚急性甲状腺炎。
Tidsskr Nor Laegeforen. 2021 Oct 11;141(2021-14). doi: 10.4045/tidsskr.21.0554. Print 2021 Oct 12.
引用本文的文献
1
Thyroid Function in the Time of COVID-19: A Systematic Review of Disease Progression and Vaccination Effect.新冠疫情期间的甲状腺功能：疾病进展与疫苗接种效果的系统评价
Int J Endocrinol Metab. 2024 Oct 27;22(3):e146857. doi: 10.5812/ijem-146857. eCollection 2024 Jul.
2
Assessment of Thyroid Status and Six Months of Follow-Up in COVID-19 Patients: A Prospective, Observational Study.COVID-19患者甲状腺状态评估及六个月随访：一项前瞻性观察研究
Cureus. 2025 Apr 8;17(4):e81896. doi: 10.7759/cureus.81896. eCollection 2025 Apr.
3
Immature granulocytes and neutrophil-to-lymphocyte ratio as markers of treatment response in subacute thyroiditis.不成熟粒细胞和中性粒细胞与淋巴细胞比值作为亚急性甲状腺炎治疗反应的标志物。
Arch Endocrinol Metab. 2024 Jun 19;68:e23012. doi: 10.20945/2359-4292-2023-0012. eCollection 2024.
4
Reversible central adrenal insufficiency in survivors of COVID-19: results from a 24-month longitudinal study.新冠病毒病幸存者的可逆性中枢性肾上腺皮质功能不全：一项为期24个月的纵向研究结果
Endocr Connect. 2024 Aug 12;13(9). doi: 10.1530/EC-24-0086. Print 2024 Sep 1.
5
Case report: Preliminary study on the diagnosis and treatment of respiratory distress in patients with giant nodular goiter complicated with severe COVID-19.病例报告：巨大结节性甲状腺肿合并重症新型冠状病毒肺炎患者呼吸窘迫的诊治初步研究
Front Med (Lausanne). 2023 Sep 6;10:1204658. doi: 10.3389/fmed.2023.1204658. eCollection 2023.
6
Inflammatory and Infectious Disorders in Endocrine Pathology.内分泌病理学中的炎症和感染性疾病。
Endocr Pathol. 2023 Dec;34(4):406-436. doi: 10.1007/s12022-023-09771-3. Epub 2023 May 20.
7
The Influence of SARS-CoV-2 Infection on the Thyroid Gland.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）感染对甲状腺的影响。
Biomedicines. 2023 Feb 18;11(2):614. doi: 10.3390/biomedicines11020614.
8
Immune-Related Thyroiditis in Patients with Advanced Lung Cancer Treated with Immune Checkpoint Inhibitors: Imaging Features and Clinical Implications.接受免疫检查点抑制剂治疗的晚期肺癌患者的免疫相关性甲状腺炎：影像特征及临床意义
Cancers (Basel). 2023 Jan 20;15(3):649. doi: 10.3390/cancers15030649.
9
Comorbidities, Associated Diseases, and Risk Assessment in COVID-19-A Systematic Review.合并症、相关疾病和 COVID-19 风险评估——系统综述。
Int J Clin Pract. 2022 Oct 31;2022:1571826. doi: 10.1155/2022/1571826. eCollection 2022.
10
Two Cases of Autoimmune Thyroid Disorders after COVID Vaccination in Dialysis Patients.两例透析患者接种 COVID 疫苗后发生自身免疫性甲状腺疾病。
Int J Mol Sci. 2022 Sep 29;23(19):11492. doi: 10.3390/ijms231911492.
本文引用的文献
1
Subacute De Quervain thyroiditis after SARS-CoV-2 infection.新型冠状病毒感染后亚急性德奎尔万甲状腺炎
Endocrinol Diabetes Nutr (Engl Ed). 2021 Dec;68(10):754-755. doi: 10.1016/j.endien.2020.10.010. Epub 2021 Dec 8.
2
Subacute Thyroiditis from COVID-19 Infection: A Case Report and Review of Literature.新冠病毒感染所致亚急性甲状腺炎：一例报告及文献综述
Eur Thyroid J. 2021 Feb;9(6):324-328. doi: 10.1159/000511872. Epub 2020 Nov 5.
3
Subacute Thyroiditis in COVID-19 Patients.新冠病毒感染患者中的亚急性甲状腺炎
Eur Thyroid J. 2021 Feb;9(6):321-323. doi: 10.1159/000511707. Epub 2020 Oct 30.
4
Potential Interaction Between SARS-CoV-2 and Thyroid: A Review.新型冠状病毒与甲状腺之间潜在的相互作用：综述。
Endocrinology. 2021 Mar 1;162(3). doi: 10.1210/endocr/bqab004.
5
Subacute thyroiditis as a presenting manifestation of COVID-19: a report of an exceedingly rare clinical entity.亚急性甲状腺炎作为 COVID-19 的表现之一：一个极其罕见的临床实体的报告。
BMJ Case Rep. 2020 Dec 18;13(12):e239953. doi: 10.1136/bcr-2020-239953.
6
SUBACUTE THYROIDITIS IN A PATIENT WITH CORONAVIRUS DISEASE 2019.一名2019冠状病毒病患者的亚急性甲状腺炎
AACE Clin Case Rep. 2020 Nov 23;6(6):e361-e364. doi: 10.4158/ACCR-2020-0524. eCollection 2020 Nov-Dec.
7
Thyroid Function Before, During, and After COVID-19.新冠病毒感染前后甲状腺功能的变化。
J Clin Endocrinol Metab. 2021 Jan 23;106(2):e803-e811. doi: 10.1210/clinem/dgaa830.
8
A case of postpartum thyroiditis following SARS-CoV-2 infection.产后甲状腺炎继发于 SARS-CoV-2 感染。
Endocr J. 2021 Mar 28;68(3):371-374. doi: 10.1507/endocrj.EJ20-0553. Epub 2020 Nov 12.
9
Thyroid Dysfunction in Relation to Immune Profile, Disease Status, and Outcome in 191 Patients with COVID-19.191 例 COVID-19 患者的甲状腺功能障碍与免疫谱、疾病状况和预后的关系。
J Clin Endocrinol Metab. 2021 Jan 23;106(2):e926-e935. doi: 10.1210/clinem/dgaa813.
10
Subacute thyroiditis might be a complication triggered by SARS-CoV-2.亚急性甲状腺炎可能是由新型冠状病毒引发的一种并发症。
Endocrinol Diabetes Nutr (Engl Ed). 2020 Oct 13;68(10):755-6. doi: 10.1016/j.endinu.2020.09.002.
Zotero 插件